1.19

0.00% 0.00

Atai Life Sciences N V (ATAI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$1.19

Aprire:

$1.19

Volume 24 ore:

2.45M

Relative Volume:

1.88

Capitalizzazione di mercato:

$199.68M

Reddito:

$314.00K

Utile/perdita netta:

$-40.23M

Rapporto P/E:

-1.2935

EPS:

-0.92

Flusso di cassa netto:

$-84.71M

1 W Prestazione:

-12.50%

1M Prestazione:

-25.16%

6M Prestazione:

-10.53%

1 anno Prestazione:

-9.85%

Intervallo 1D:

$1.15

$1.26

Intervallo di 1 settimana:

$1.15

$1.41

Portata 52W:

$1.03

$2.85

Atai Life Sciences N V Stock (ATAI) Company Profile

Nome

Atai Life Sciences N V

Settore

Healthcare (1176)

Industria

Biotechnology (673)

Telefono

49 89 2153 9035

Indirizzo

WALLSTRASSE 16, BERLIN

Dipendente

Cinguettio

Prossima data di guadagno

2024-12-11

Ultimi documenti SEC

ATAI's Discussions on Twitter

Confronta ATAI con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ATAI Atai Life Sciences N V	1.19	199.68M	314.00K	-40.23M	-84.71M	-0.28
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Atai Life Sciences N V Stock (ATAI) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-11-18	Reiterato	H.C. Wainwright	Buy
2024-04-03	Aggiornamento	Maxim Group	Hold → Buy
2022-11-01	Iniziato	Loop Capital	Buy
2021-11-30	Iniziato	Maxim Group	Buy
2021-11-11	Iniziato	ROTH Capital	Buy
2021-10-18	Iniziato	H.C. Wainwright	Buy
2021-09-01	Iniziato	Jefferies	Buy
2021-07-13	Iniziato	Berenberg	Buy
2021-07-13	Iniziato	Canaccord Genuity	Buy
2021-07-13	Iniziato	Cantor Fitzgerald	Buy
2021-07-13	Iniziato	Citigroup	Buy
2021-07-13	Iniziato	Cowen	Outperform
2021-07-13	Iniziato	Credit Suisse	Outperform
2021-07-13	Iniziato	RBC Capital Mkts	Sector Perform
2021-07-08	Iniziato	Aegis Capital	Buy

Mostra tutto

Atai Life Sciences N V Borsa (ATAI) Ultime notizie

Dec 06, 2024

Thiel-Backed Psychedelic Firm Atai to Buy Stake in Beckley - MSN

Dec 06, 2024

Nov 20, 2024

Atai Life Sciences stock target cut, retains buy rating on developments - Investing.com India

Nov 20, 2024

Nov 19, 2024

Oxbridge Re Holdings Among 3 US Penny Stocks To Watch - Simply Wall St

Nov 19, 2024

Nov 15, 2024

RFK and the 'MAHA Trade': Vaccine makers down, psychedelic shares up - Seeking Alpha

Nov 15, 2024

Nov 13, 2024

Atai Life Sciences Advances Psychedelic Treatments in Q3 2024 - TipRanks

Nov 13, 2024

atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates - The Manila Times

Nov 13, 2024

Atai Life Sciences N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

atai Life Sciences Advances Psychedelic Pipeline as FDA Clears DMT Depression Treatment | ATAI Stock News - StockTitan

Nov 13, 2024

Oct 21, 2024

374Water And 2 Other Promising US Penny Stocks To Watch - Simply Wall St

Oct 21, 2024

Oct 15, 2024

Are ATAI Life Sciences N.V.’shares a good deal? - US Post News

Oct 15, 2024

Insider Sale Alert: ATAI Life Sciences N.V. [ATAI] – Is it Time to sell? - Knox Daily

Oct 15, 2024

atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit - StockTitan

Oct 15, 2024

Oct 11, 2024

Selling Buzz: ATAI Life Sciences N.V. [ATAI] 10% Owner ATAI Life Sciences N.V. sells 2,660,000 shares of the company - Knox Daily

Oct 11, 2024